Skip to main content
    R

    Rockwell Medical Inc (RMTI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $6.61
    -0.15 (-2.22%)

    Market Cap: $27.92M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Rockwell Medical Inc (RMTI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Rockwell Medical (RMTI) has a market cap of $27.92M and an enterprise value of $26.34M. Its share count is up 10.26% from a year earlier.

    Total Valuation

    Enterprise value is 5.66% below the market cap, as cash exceeds debt.

    Market Cap$27.92M
    Enterprise Value$26.34M
    Latest price (Nov 17, 2026)$6.61

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.34% in the quarter ended Sep 30, 2026 and shrank 64.52% a year over 2 years.

    Shares Outstanding3.97M
    Shares Change (YoY)+10.26%
    Shares Change (QoQ)+0.34%
    Share Count Growth (2Y CAGR)-64.52%

    Valuation Ratios

    Sales and book value multiples are 0.4x and 0.8x. Its year-end P/S ranged from 0.2x to 8.2x from 2016 to 2025.

    P/S Ratio0.4x
    Forward P/S0.4x
    P/B Ratio0.8x
    P/TBV Ratio1.1x
    P/FCF Ratio31.7x
    P/OCF Ratio10.4x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 29.8x free cash flow.

    EV / Sales0.4x
    EV / FCF29.8x

    Price Statistics

    The stock is down 28.08% over 52 weeks and trades 14.71% below its 50-day average.

    Beta (1Y)0.58
    52-Week Change-28.08%
    1-Month Change-11.75%
    3-Month Change-11.87%
    6-Month Change-17.21%
    5-Year Change-88.02%
    10-Year Change-98.89%
    Total Return (1Y)-28.08%
    Total Return (3Y CAGR)-31.64%
    Total Return (5Y CAGR)-34.45%
    Return vs SPY (1Y)-36.03%
    Max Drawdown (1Y)-58.81%
    Max Drawdown (3Y)-88.84%
    Sharpe Ratio (1Y)-0.42
    Correlation with SPY (1Y)0.12
    50-Day Average$7.75
    200-Day Average$8.01
    52-Week Range$4.88 to $12.90
    RSI (14 Days)38.4
    Average Volume (20 Days)23.23K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.47x current liabilities, and total debt is 0.27x shareholder equity.

    Current Ratio2.47x
    Quick Ratio2.27x
    Debt / Equity0.27x
    Debt / FCF10.93x
    Interest Coverage0.54x

    Returns and Efficiency

    Return on invested capital is -8.79% over the last 12 months, against a 5-year average of -36.45%.

    Return on Equity (ROE)-17.07%
    Return on Assets (ROA)-9.91%
    Return on Invested Capital (ROIC)-8.79%
    Return on Capital Employed (ROCE)-11.18%
    ROA (5Y Average)-26.72%
    ROIC (5Y Average)-36.45%
    Asset Turnover1.27x
    Inventory Turnover20.67x
    Receivables Turnover8.02x
    Cash Conversion Cycle42 days

    Scores

    RMTI has an Altman Z-Score of -7.89, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-7.89
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $72.58M over the last 12 months is down 3.96% from the 12 months before.

    Revenue$72.58M
    Revenue Growth (YoY)-3.96%
    Gross Profit$13.13M
    Operating Income-$5.16M
    Pretax Income-$5.66M
    Net Income-$5.66M
    EBITDA-$2.28M
    EBIT-$4.70M
    Reported EPS (TTM)-$1.34

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 58.04% of the $57.08M in total assets.

    Cash and Equivalents$10.63M
    Total Debt$9.05M
    Net Cash$1.58M
    Net Cash Per Share$0.40
    Working Capital$22.10M
    Shareholder Equity$33.13M
    Book Value Per Share$8.34
    Tangible Book Value$22.97M
    Tangible Book Per Share$5.78
    Total Assets$57.08M
    Total Liabilities$23.95M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.85M of capital spending, operating cash flow left $828.00K of free cash flow.

    Operating Cash Flow$2.68M
    Capital Expenditures$1.85M
    Free Cash Flow$828.00K
    FCF Per Share$0.21
    Depreciation and Amortization$2.41M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -7.11%, against a 5-year average of -17.24%.

    Gross Margin18.09%
    Operating Margin-7.11%
    Pretax Margin-7.79%
    Net Margin-7.79%
    EBITDA Margin-3.15%
    EBIT Margin-6.47%
    FCF Margin1.14%
    Gross Margin (5Y Average)9.24%
    Operating Margin (5Y Average)-17.24%
    Net Margin (5Y Average)-19.33%

    Growth

    Revenue fell 1.65% a year over 3 years.

    Revenue Growth (3Y CAGR)-1.65%
    Revenue Growth (5Y CAGR)+2.17%
    Book Value Per Share Growth (2Y CAGR)+12.38%
    Tangible Book Per Share Growth (2Y CAGR)+41.34%

    Revenue and profit by year

    Dividends and Yields

    RMTI does not pay a dividend. Its free cash flow yield is 3.15%.

    FCF Yield3.15%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jul 1, 2026.

    Last Split DateJul 1, 2026
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 8 similar companies, RMTI has the 7th highest P/S and the 3rd highest ROIC.

    P/S Ratio0.4x vs 1.7x median
    ROIC-8.79% vs -28.50% median
    Revenue Growth (Trailing 4 Quarters, YoY)-3.96% vs +13.87% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.54% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.54%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About RMTI

    What is RMTI's market cap?

    Rockwell Medical has a market cap of $27.92M. Its enterprise value, which adds debt and subtracts cash, is $26.34M.

    How many shares of RMTI are outstanding?

    Rockwell Medical has 3.97M shares outstanding. The count is up 10.26% from a year earlier.

    Does RMTI pay a dividend?

    No. Rockwell Medical does not pay a dividend.

    How much debt does RMTI have?

    Rockwell Medical has $9.05M of total debt and $10.63M of cash and equivalents, a net cash position of $1.58M.